AGP Executive Report
Last update: 10 hours agoTrade & Pharma Ties: India’s Commerce Minister Piyush Goyal will visit Switzerland (Berne, June 12–13) to push the India–EFTA Trade and Economic Partnership Agreement (TEPA) rollout, including talks with Swiss officials and leaders of the Swiss pharmaceutical industry—an effort that also directly involves Liechtenstein as part of the EFTA group. Health & Access Abroad: A UK travel health warning says nearly half of Brits lack a GHIC, which can help cover state-provided medical care in Europe at local cost—urging travellers to get it before departure and still keep travel insurance. EU Migration Pressure: Switzerland’s upcoming vote on a population cap could strain EU relations, with Brussels stressing that free movement is central to the relationship. Medical Innovation: Medexus says Europe’s conditional approval for a cell therapy (Zemcelpro®/dorocubicel) is now tied to a Canada license and supply deal, with commercialization expected from 2028. Liechtenstein in the News: A piece on Liechtenstein highlights how the principality is leaning on regulation and cross-border access to grow its fintech ambitions despite its small size. Science & Health Research: A new space life sciences experiment launched from Sweden includes a partnership with Switzerland and Liechtenstein, studying how human immune cells respond to gravity changes.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
